We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 4.76% | 1.10 | 1.00 | 1.10 | 1.05 | 1.05 | 1.05 | 397,039 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.82 | 1.88M |
From Apr 2019 to Apr 2024
TIDMMSYS
RNS Number : 3044Z
Microsaic Systems plc
16 May 2019
16 May 2019
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Board Change
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, following the announcement on 11 March 2019 at the time of the Company's final results, announces that Professor Andrew Holmes, Non-Executive Director and Company Secretary, has stepped down from the Board with immediate effect.
The Board thanks Andrew for his dedication and support to the Company over the last 18 years. Bevan Metcalf, Finance Director, has taken on the additional responsibilities of Company Secretary.
Enquiries: Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD & Company Secretary +44 (0) 1483 751 577 N+1 Singer (Nominated Adviser & Broker) Shaun Dobson (Corporate Finance) Tom Salvesen (Corporate Broking) +44 (0)20 7496 3000 IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong Florence Chandler +44 (0)20 3934 6630
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD(R), is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAAFMJTMBMBBAL
(END) Dow Jones Newswires
May 16, 2019 09:06 ET (13:06 GMT)
1 Year Microsaic Systems Chart |
1 Month Microsaic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
